Position Papers
06.09.2011 - Nanobiotechnology / Nanomedicine
By international comparison, Germany holds a strong position in the field of nanotechnology. Nanobiotechnology has the potential of opening up new or improved/earlier diagnostic or therapeutic opportunities for diseases that were previously insufficiently curable or completely incurable.
27.05.2011 - Biosimilars
Biopharmaceuticals are manufactured with the help of living cells (e.g. hamster cells) or microorganisms (bacteria like E. coli or yeasts). In contrast to chemical-synthetic pharmaceuticals, their quality is essentially determined by the living organisms used and the manufacturing process. Even small modifications to the manufacturing process may lead to differences in the product that can change the drug's efficacy or tolerability in a sustained manner.
Suggest page
Print page
Bookmark page